← All stocks

Sanara MedTech Inc.

SMTI Net buying
CIK 0000714256 #3534 in the set updated 21 Sep 2026
Bought (120 mo)
$10.00M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$270.36K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$270.36K
18 of 18 sales
Net
+$9.73M
+$9.73M against sales at will

By person

25 insiders · 24 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Nixon Ronald T
Director
$8.00M (1)
+$8.00M
1,032,052
11.23%
$34.06M
STUCKERT JAMES W
Director
$1.50M (1)
+$1.50M
66,061,475
$2.18B
+76.7%
HOWELL S ODEN JR
Director
$500.00K (1)
+$500.00K
42,730,823
$1.41B
+7,385%
Fleming Zachary B.
Chief Executive Officer
$154.93K (12)
−$154.93K
48,854
0.5317%
$1.61M
Bowman Shawn M.
Pres. - Strat. Partnerships
$115.43K (6)
−$115.43K
11,469
0.1248%
$378.48K
Siedhoff John Christopher
Director
7,150,000
77.82%
$235.95M
+2.1%
HUTCHINSON DEBORAH JENKINS
President
2,750,000
29.93%
$90.75M
+22.2%
CGI Cellerate RX, LLC entity
10% owner
2,452,731
26.69%
$80.94M
Rubinfeld Philip J
Director
500,000
5.44%
$16.50M
+42.9%
Yon Seth D
Chief Executive Officer
105,885
1.15%
$3.49M
−9.6%
DeSutter Robert Andrew
Director
28,740
0.3128%
$948.42K
McNeil Michael D.
Ch. Acct. & Ch. Admin. Officer
28,587
0.3111%
$943.37K
Morrison Christopher A.
President - Telehealth Svcs.
28,032
0.3051%
$925.06K
+34.1%
Salamone Ann Beal
Director
26,858
0.2923%
$886.31K
Ortwein Sara N
Director
25,415
0.2766%
$838.70K
Waldrop Jacob A.
Chief Operating Officer
24,377
0.2653%
$804.44K
−12.7%
TANZBERGER ERIC D
Director
22,966
0.2500%
$757.88K
Carmena J Michael
Principal Executive Officer
22,113
0.2407%
$729.73K
Mack Roszell III
Director
21,842
0.2377%
$720.79K
Taylor Elizabeth B
Chief Financial Officer
17,632
0.1919%
$581.86K
−30.5%
Thorpe Kenneth E
Director
16,945
0.1844%
$559.19K
Major Eric D
Director
14,232
0.1549%
$469.66K
McMahon Rebecca E
President - R&D
9,595
0.1044%
$316.64K
Myers Keith G
Director
9,325
0.1015%
$307.73K
Mackey Ashley M
Controller
5,067
0.0551%
$167.21K
−36.8%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 160
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 18
Transactions with no price 0
Shares from compensation/vesting 77,032,849
Sales filed before the plan box existed 18
History held since 31 Mar 2017